FeesSafety
Pluang+

Anthropic plans IPO to fund AI-driven bioscience, with potential future ties to Ginkgo Bioworks' lab automation.

Market News
19 Nov 2026, 08:56 WIB
Alex Carchidi
View Source
Bullish
Anthropic plans IPO to fund AI-driven bioscience, with potential future ties to Ginkgo Bioworks' lab automation.

Anthropic is set to go public on November 19, raising tens of billions to boost its AI capabilities in bioscience, focusing on lab automation and robotics. Ginkgo Bioworks, a leader in automated biotech labs, collaborates with OpenAI but has no current public ties with Anthropic. While Ginkgo's advanced robotic lab platform is promising, Anthropic's IPO does not guarantee immediate business for Ginkgo. Investors interested in Anthropic's bioscience efforts can consider its stock post-IPO, but Ginkgo's stock isn't directly impacted yet by Anthropic's move.

While Anthropic prepares for its IPO to advance AI in bioscience, Ginkgo Bioworks' stock shows steady interest among investors. On Pluang, DNA trades at USD 8.44 with a 1-day gain of 1.44% as of Nov 19, 2026 09:11 WIB. The stock's market cap stands at $539.34M, and most Pluang users favor buying, with 94% buy orders compared to 6% sell.

More News (DNA)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App